Drug recall · July 19, 2017
0.9% Sodium Chloride Injection USP recall
Why: Lack of Assurance of Sterility: Customer complaints for leaking bags.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
0.9% Sodium Chloride Injection USP, 250 mL VIAFLEX Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015; Distributed in Canada by Baxter Corporation, Toronto, Ontario, Canada, Product Code: 2B1322, NDC 0338-0049-02.
- Lots / codes
Lot: Y229153, Exp 09/30/18
- Quantity
- 131,904 bags
- Company
- Baxter Healthcare Corporation, Deerfield, IL
- Distribution
- Nationwide in USA
- Initiated
- July 6, 2017 · Voluntary: Firm initiated
- Classified
- July 7, 2017
- Reported
- July 19, 2017
- Ended
- April 29, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sodium chloride
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.